Abingdon Health PLC
LSE:ABDX
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.75
12
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ABDX stock under the Base Case scenario is 12.01 GBX. Compared to the current market price of 7.25 GBX, Abingdon Health PLC is Undervalued by 40%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Abingdon Health PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ABDX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Abingdon Health PLC
Balance Sheet Decomposition
Abingdon Health PLC
Current Assets | 3.8m |
Cash & Short-Term Investments | 2m |
Receivables | 1.3m |
Other Current Assets | 411k |
Non-Current Assets | 1.1m |
Long-Term Investments | 15k |
PP&E | 977k |
Intangibles | 76k |
Current Liabilities | 2.1m |
Accounts Payable | 2m |
Other Current Liabilities | 97k |
Non-Current Liabilities | 911k |
Long-Term Debt | 911k |
Earnings Waterfall
Abingdon Health PLC
Revenue
|
5.3m
GBP
|
Cost of Revenue
|
-2.3m
GBP
|
Gross Profit
|
3.1m
GBP
|
Operating Expenses
|
-5.6m
GBP
|
Operating Income
|
-2.5m
GBP
|
Other Expenses
|
306k
GBP
|
Net Income
|
-2.2m
GBP
|
Free Cash Flow Analysis
Abingdon Health PLC
GBP | |
Free Cash Flow | GBP |
ABDX Profitability Score
Profitability Due Diligence
Abingdon Health PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.
Score
Abingdon Health PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.
ABDX Solvency Score
Solvency Due Diligence
Abingdon Health PLC's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Abingdon Health PLC's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABDX Price Targets Summary
Abingdon Health PLC
Dividends
Current shareholder yield for ABDX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. The company is headquartered in York, North Yorkshire and currently employs 151 full-time employees. The company went IPO on 2020-12-15. The firm operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).
Contact
IPO
Employees
Officers
The intrinsic value of one ABDX stock under the Base Case scenario is 12.01 GBX.
Compared to the current market price of 7.25 GBX, Abingdon Health PLC is Undervalued by 40%.